target

Avexis

bidder

Novartis

£5,275m

60 dealmakers

target

Glaxosmithkline Consumer Healthcare Holdings

bidder

Glaxosmithkline

£9,180m

45 dealmakers

target

Ifm Tre

bidder

Novartis

£1,204m

11 dealmakers

target

XIIDRA

bidder

Novartis

£4,066m

52 dealmakers

target

Alcon

bidder

Institutional Investors

£20,634m

92 dealmakers

target

The Medicines Company

bidder

Novartis

£7,553m

43 dealmakers

target

FREENOME

bidder

T. Rowe Price Group

£126m

30 dealmakers

target

Poseida Therapeutics

bidder

Vivo Capital

£109m

12 dealmakers

target

AMBLYOTECH

bidder

Novartis

value n/a

3 dealmakers

target

Vedere Bio

bidder

Novartis

£215m

21 dealmakers

target

Novartis (two Manufacturing Sites)

bidder

Siegfried Holding

value n/a

5 dealmakers

target

Cadent Therapeutics

bidder

Novartis

£576m

6 dealmakers

target

SOMALOGIC

bidder

Janus Henderson Investors

£891m

63 dealmakers

target

CELLERYS

bidder

Novartis

value n/a

3 dealmakers

target

Novartis (roche Shares)

bidder

Roche Holdings

£15,166m

34 dealmakers

target

CLEERLY

bidder

Mirae Asset Capital Co

£159m

9 dealmakers

target

H1

bidder

Menlo Ventures

£18m

6 dealmakers

target

International Service Laboratory (isl)

bidder

Sgs

value n/a

4 dealmakers

target

SANDOZ

bidder

Institutional Investors

£9,660m

7 dealmakers

target

Sandoz China Manufacturing Plant In Zhongshan

bidder

Jiuzhou Pharmaceutical

£14m

11 dealmakers

target

XIIDRA

bidder

Bausch + Lomb

£1,974m

59 dealmakers

target

Cellforcure

bidder

SEQENS

value n/a

10 dealmakers

target

Sanreno Therapeutics

bidder

Novartis

value n/a

2 dealmakers